Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 0 | 18 | 0 | 1 |
| Accounts payable and accrued liabilities | 612 | -6,440 | -476 | 624 | 813 |
| Other Working Capital | 1,160 | -6,734 | -18 | 61 | 675 |
| Other Operating Activity | -3,276 | 2,882 | -3,282 | -3,061 | -3,637 |
| Operating Cash Flow | $-1,505 | $-10,291 | $-3,758 | $-2,376 | $-2,147 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | -1 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-1 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 190 | -514 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 4 | 0 | 0 |
| Financing Cash Flow | $0 | $190 | $-511 | $N/A | $N/A |
| Exchange Rate Effect | 0 | 0 | 0 | -237 | 38 |
| Beginning Cash Position | 2,497 | 12,598 | 16,868 | 1,223 | 3,332 |
| End Cash Position | 992 | 2,497 | 12,598 | 16,868 | 1,223 |
| Net Cash Flow | $-1,505 | $-10,101 | $-4,270 | $15,883 | $-2,147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,505 | -10,291 | -3,758 | -2,376 | -2,147 |
| Free Cash Flow | -1,505 | -10,291 | -3,758 | -2,376 | -2,147 |